CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net service revenue	$ 1,249,344	$ 1,440,836	$ 1,418,464
Cost of service, excluding depreciation and amortization	717,996	810,704	750,439
General and administrative expenses:
Salaries and benefits	302,564	327,111	319,634
Non-cash compensation	6,519	7,217	8,292
Other	164,991	182,345	178,880
Provision for doubtful accounts	15,882	21,011	12,646
Depreciation and amortization	36,871	39,200	37,808
U.S. Department of Justice settlement	150,000	0	0
Goodwill and other intangibles impairment charge	9,492	162,103	579,955
Operating expenses	1,404,315	1,549,691	1,887,654
Operating loss	(154,971)	(108,855)	(469,190)
Other income (expense):
Interest income	54	65	231
Interest expense	(4,412)	(12,116)	(8,788)
Equity in earnings from equity investments	1,520	1,695	1,494
Miscellaneous, net	4,334	3,934	(794)
Total other income (expense), net	1,496	(6,422)	(7,857)
Loss before income taxes	(153,475)	(115,277)	(477,047)
Income tax benefit	58,773	20,020	102,739
Loss from continuing operations	(94,702)	(95,257)	(374,308)
Discontinued operations, net of tax	(3,073)	(3,326)	(8,034)
Net loss	(97,775)	(98,583)	(382,342)
Net loss (income) attributable to noncontrolling interests	1,597	14,995	(122)
Net loss attributable to Amedisys, Inc.	(96,178)	(83,588)	(382,464)
Basic earnings per common share:
Loss from continuing operations attributable to Amedisys, Inc. common stockholders	$ (2.98)	$ (2.68)	$ (13.05)
Discontinued operations, net of tax	$ (0.10)	$ (0.11)	$ (0.28)
Net loss attributable to Amedisys, Inc. common stockholders	$ (3.08)	$ (2.79)	$ (13.33)
Weighted average shares outstanding	31,247	29,896	28,693
Diluted earnings per common share:
Loss from continuing operations attributable to Amedisys, Inc. common stockholders	$ (2.98)	$ (2.68)	$ (13.05)
Discontinued operations, net of tax	$ (0.10)	$ (0.11)	$ (0.28)
Net loss attributable to Amedisys, Inc. common stockholders	$ (3.08)	$ (2.79)	$ (13.33)
Weighted average shares outstanding	31,247	29,896	28,693
Amounts attributable to Amedisys, Inc. common stockholders:
Loss from continuing operations	(93,105)	(80,262)	(374,430)
Discontinued operations, net of tax	(3,073)	(3,326)	(8,034)
Net loss attributable to Amedisys, Inc.	$ (96,178)	$ (83,588)	$ (382,464)